Clinical experience with the carbomedics valve: Early results with a new bileaflet mechanical prosthesis

25Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Between January 1989 and August 1992, 612 CarboMedics mechanical prostheses (CarboMedics, Inc., Austin, Tex.) (295 mitral, 308 aortic, and 9 tricuspid) were implanted in 504 patients: 189 patients had isolated mitral valve replacement, 209 had isolated aortic valve replacement, and 106 had multiple valve replacement. The total follow-up was 1182 patient-years. The hospital mortality rate was 7.4% for mitral valve replacement, 5.3% for aortic valve replacement, and 13.2% for multiple valve replacement. Linearized rates for the different complications for mitral valve replacement, aortic valve replacement, and multiple valve replacement (in events per 100 patient-years) were, respectively, as follows: late mortality, 2.6 ± 0.8, 1.5 ± 0.5, and 3.9 ± 1.3; thromboembolim, 3.7 ± 0.9, 3.1 ± 0.8, and 3.9 ± 1.3; valve thrombosis, 0.5 ± 0.3 for mitral valve replacement and 0.4 ± 0.4 for multiple valve replacement; anticoagulant- related hemorrhage, 2.8 ± 0.8, 1.9 ± 0.6, and 2.6 ± 1.1; nonstructural dysfunction, 1.6 ± 0.6, 0.8 ± 0.4, and 3.5 ± 1.2; and reoperation, 1.1 ± 0.5, 0.4 ± 0.3, and 3.1 ± 1.1. Actuarial estimates of freedom from the different complications for mitral valve replacement, aortic valve replacement, and multiple valve replacement (at 5 years of follow-up for mitral valve replacement and aortic valve replacement and 4.5 years for multiple valve replacement) were, respectively, as follows: overall death, 83% ± 4%, 89% ± 2%, and 76% ± 4%; thromboembolism or valve thrombosis, 88% ± 3%, 91% ± 2%, and 86% ± 5%; anticoagulant-related hemorrhage, 89% ± 3%, 95% ± 2%, and 90% ± 5%; nonstructural dysfunction, 97% ± 1%, 98% ± 1%, and 91% ± 3%; and reoperation, 96% ± 2%, 99% ± 1%, and 87% ± 5%. There were no instances of prosthetic structural dysfunction. The performance of the CarboMedics valve is satisfactory at 5 years of follow-up but thromboembolic and hemorrhagic phenomena are still serious complications of mechanical prostheses.

Cite

CITATION STYLE

APA

Nistal, J. F., Hurle, A., Revuelta, J. M., & Gandarillas, M. (1996). Clinical experience with the carbomedics valve: Early results with a new bileaflet mechanical prosthesis. Journal of Thoracic and Cardiovascular Surgery, 112(1), 59–68. https://doi.org/10.1016/S0022-5223(96)70178-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free